LAMISIL 1 %, cream tube, 15 g
Active ingredients: Terbinafine hydrochloride, Terbinafine
Commercialized according to BDPMDispensing in France: Prescription only
Creamtube, 15 gcutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- LAMISIL 1 %, crème
- Pharmaceutical form
- crème
- Route of administration
- cutanée
- Presentation description
- 1 tube(s) laminé aluminium de 15 g
- Marketing authorisation holder
- KARO HEALTHCARE (SUEDE)
- Reimbursement according to BDPM
- 30 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 2 Aug 2021
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65054729CIP73015889CIP133400930158890Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE DE TERBINAFINEcrème | 1 g · 100 g | SA |
| TERBINAFINEcrème | 0,88 g · 100 g | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.